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Signaling networks controlled by Sonic hedgehog
(SHH) and the transcription factor Atoh1 regulate
the proliferation and differentiation of cerebellar
granule neuron progenitors (GNPs). Deregulations in
those developmental processes lead tomedulloblas-
toma formation, the most common malignant brain
tumor in childhood. Although the protein Atoh1 is a
key factor during both cerebellar development and
medulloblastoma formation, up-to-date detailed
mechanisms underlying its function and regulation
have remained poorly understood. Here, we report
that SHH regulates Atoh1 stability by preventing its
phosphodependent degradation by the E3 ubiquitin
ligase Huwe1. Our results reveal that SHH and
Atoh1 contribute to a positive autoregulatory loop
promoting neuronal precursor expansion. Conse-
quently, Huwe1 loss in mouse SHHmedulloblastoma
illustrates the disruption of this developmental
mechanism in cancer. Hence, the crosstalk between
SHH signaling and Atoh1 during cerebellar develop-
ment highlights a collaborative network that could
be further targeted in medulloblastoma.
INTRODUCTION
Deregulations of fundamental developmental processes are key
events in the pathogenesis of cancer, including medulloblas-
toma (MB), the most common malignant pediatric brain tumor
arising from the developing cerebellum. During cerebellar devel-
opment, at birth, mouse granule neuron progenitors (GNPs)
undergo massive proliferation driven by the mitogen Sonic
hedgehog (SHH) in the external granule layer (EGL) (Dahmane
and Ruiz i Altaba, 1999; Wallace, 1999; Wechsler-Reya and
Scott, 1999). The morphogen SHH is critical for cerebellar devel-
opment, as it activates proliferation through its action on theDeveltransmembrane receptor Patched1 (Ptch1), thereby releasing
inhibition of another transmembrane receptor, Smoothened
(Smo). Activated Smo allows downstream activation of SHH
signaling, including the nuclear translocation of Gli transcription
factors, to induce the expression of pro-proliferative genes.
Within 3 weeks, GNPs have exited the cell cycle, migrated,
and differentiated into neurons residing in the internal granule
layer (IGL) of the mature cerebellum. Defects in this program,
caused by constitutive activation of SHH signaling, induce a
distinct subgroup of MB in which Atoh1 is found overexpressed
(Roussel and Hatten, 2011). Atoh1 is a proneural basic helix-
loop-helix (bHLH) transcription factor required for GNP forma-
tion, acting as a lineage-dependency transcription factor in
SHHMB (Ben-Arie et al., 1997; Briggs et al., 2008a, 2008b; Flora
et al., 2009; Ayrault et al., 2010). After birth, the expression of
Atoh1 in the cerebellum is restricted to proliferating GNPs and
abolished in postmitotic neurons in the IGL (Ben-Arie et al.,
1997). Accumulation of Atoh1 in collaboration with SHH
signaling transforms GNPs into MB-initiating cells by inhibiting
neuronal differentiation (Ayrault et al., 2010). Thus, fine-tuned
regulation of Atoh1 both spatially and temporally is crucial for
normal development and tumor formation. However, up-to-
date modules that control Atoh1 are still under investigation
and remain to be elucidated.
Here, we show that SHH signaling controls Atoh1 levels by
inhibiting the recruitment of Atoh1 by the homolog of E6AP
carboxyl terminus (HECT) domain E3 ubiquitin ligase Huwe1 in
neuronal progenitors through a phosphodependent mechanism.
We describe a mechanism consisting of a positive regulatory
loop between SHH and Atoh1 during cerebellar development
that is disrupted in tumor cells. Together, our findings uncover
a pathway that could be used for therapeutic strategies to
eradicate MB.
RESULTS
Atoh1 Phosphorylation at Serine 328 and Serine
339 Controls Its Stability
To study the molecular mechanism controlling Atoh1 function,
we investigated the role of posttranslational modifications onopmental Cell 29, 649–661, June 23, 2014 ª2014 Elsevier Inc. 649
Figure 1. Atoh1 Phosphorylation at S328 and S339 Controls Its
Stability
(A) Immunoblotting analysis of Atoh1-HA subjected to Lambda phosphatase
treatment (l-PPase). Both the phosphorylated form (upper arrow) and the
unphosphorylated form (lower arrow) of Atoh1 are indicated.
(B) Sequence alignment of Atoh1 protein across indicated species. S328 and
S339 phosphorylation sites are highlighted with an asterisk (*). bHLH, basic
helix-loop-helix; N, N-terminal portion; C, C-terminal portion.
(C) HEK293T cells transiently expressing Atoh1-HA or indicated phosphory-
lation mutants. Cells were treated with 10 mM of cycloheximide (Chx) for the
indicated time and were analyzed by immunoblot using anti-HA and anti-Actin
antibodies.
(D) Quantification of Atoh1/Actin remaining protein. Data are expressed as
means ± SD (n = 3).
(E) HEK293T cells were transfected with indicated plasmids. Luciferase
activity was monitored 48 hr after transfection and normalized to Renilla
luciferase activity. Data are expressed as means ± SD (n = 3).
(F) HEK293T cells were transfected with indicated plasmids. Lysates were im-
munoblotted with antibodies against Atoh1 p-S328, Atoh1 p-S339, HA, and Actin.
(G) Atoh1-HA was immunoprecipitated from HEK293T cells previously trans-
fected with pcDNA3-Atoh1-HA and subjected to Lambda phosphatase
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protein. Immunoblot analysis of human embryonic kidney 293T
(HEK293T) cells overexpressing Atoh1 tagged with hemaggluti-
nin (HA) revealed that after Lambda protein phosphatase treat-
ment, Atoh1 protein migrated faster compared to the untreated
condition, strongly suggesting that Atoh1 was phosphorylated
(Figure 1A). Usingmass spectrometry on Atoh1-3xFlag (Atoh1-F)
purified from HEK293T cells, we identified 12 phosphorylation
sites (Figure S1A available online). To decipher whether phos-
phorylation was implicated in Atoh1 stability, we mutated each
phosphorylated residue into alanine (A) and determined the
half-life of each mutant protein in HEK293T. Only two single
mutants, Atoh1-serine 328 alanine-HA (Atoh1-S328A-HA) and
Atoh1-serine 339 alanine-HA (Atoh1-S339A-HA), located in
Atoh1’s C-terminal domain (Figure 1B), as well as the double
mutant Atoh1-S328A-S339A-HA (Atoh1-2SA-HA), exhibited an
increased half-life compared to Atoh1-HA wild-type (100, 130,
245, and 38 min, respectively; n = 3; Figures 1C and 1D). We
further confirmed in postnatal day 7 (P7) GNPs that Atoh1-
2SA-HA exhibited an increased half-life compared to Atoh1-HA
wild-type (Figure S1B). The increased half-life observed with
the Atoh1-2SA-HA mutant was associated with an increase in
transcriptional activity in HEK293T cells (Figure 1E). Thus, both
phosphorylation sites S328 and S339 are critical for Atoh1 stabil-
ity and function. To investigate Atoh1 phosphorylation at S328
and S339, we generated phosphospecific antibodies (a-Atoh1
p-S328 and a-Atoh1 p-S339) that were further validated by
immunoblotting experiments (Figures 1F and 1G).
Phosphorylation at S328 and S339 Mediates the
Atoh1-Huwe1 Complex
To get insights into themechanism controlling Atoh1 stability, we
investigated its phosphospecific partners. We generated a
tagged version of both Atoh1wild-type andmutant 2SA, in which
an epitope containing three copies of the Flag tag was linked to
HA and fused to the C terminus of Atoh1 (Atoh1-FH and
Atoh1-2SA-FH). We first confirmed that the Atoh1-FH construct
was as transcriptionally active as the untaggedAtoh1 (Figure S2).
We then performed sequential Flag/HA tandem affinity purifica-
tion (TAP) andmultidimensional protein identification technology
(MudPIT) analysis by liquid chromatography-tandem mass
spectrometry (LC-MS/MS) using HEK293T cells that overex-
press untagged Atoh1, Atoh1-FH, and Atoh1-2SA-FH. Among
the list of proteins that were differentially pulled down, one of
the top proteins was HUWE1. HUWE1 belongs to the HECT
family of E3 ubiquitin ligase and is responsible for the ubiquityla-
tion and proteasomal degradation of proteins (Chen et al., 2005;
Zhong et al., 2005; Hall et al., 2007; Zhao et al., 2008b; Noy et al.,
2012). HUWE1 was strongly associated with Atoh1-FH, whereas
it was barely detectable in complexes with Atoh1-2SA-FH (Fig-
ure 2A; Table S1). We next validated Atoh1-HUWE1 interaction
by coimmunoprecipitation experiments. E47, an E-protein that
was already known to bind to Atoh1 (Flora et al., 2007), and
HUWE1 were coprecipitated in lysates from HEK293T cells
overexpressing Atoh1-FH (Figure 2B). Moreover, Atoh1-HA
was found coimmunoprecipitated with endogenous HUWE1 intreatment (l-PPase). Resulting complexes were analyzed by immunoblotting
with anti-Atoh1 p-S328, anti-Atoh1 p-S339, and anti-HA.
nc.
Figure 2. Phosphodependent Interaction
between Atoh1 and the E3 Ubiquitin Ligase
Huwe1
(A) Tandem affinity-purified Atoh1, Atoh1-FH, and
Atoh1-2SA-FH from HEK293T cells run on
SDS-PAGE gel and stained with colloidal blue.
Proteins identified by mass spectrometry are
indicated (black arrows).
(B) Lysates of HEK293T cells overproducing Atoh1
or Atoh1-FH were subjected to immunoprecipita-
tion with antibodies against Flag and HA. The
resulting complexes were immunoblotted with
antibodies against Atoh1, E47, and HUWE1. Anti-
Actin antibody was used as a negative control.
Asterisk (*) indicates the light immunoglobulin
chain (IgG).
(C) Lysates of HEK293T cells overproducing
Atoh1-HA were subjected to immunoprecipitation
with anti-HUWE1 antibody and normal rabbit
IgG as a control. The resulting complexes were
immunoblotted with anti-HA and anti-HUWE1
antibodies.
(D) Atoh1-HA was immunoprecipitated from
HEK293T cells transfected with pcDNA3-Atoh1-
HA and left untreated or treated with Lambda
phosphatase (l-PPase). Complexes were sub-
jected to immunoblotting analysis using anti-
bodies against HUWE1, Atoh1 p-S328, Atoh1
p-S339, and HA.
(E) Lysates of HEK293T cells overproducing
Atoh1, Atoh1-FH, Atoh1-S328A-FH, Atoh1-
S339A-FH, or Atoh1-2SA-FH were subjected to
immunoprecipitation with anti-Flag followed by
anti-HA antibody. The resulting complexes were
immunoblotted with antibodies against Flag and
HUWE1.
(F) Lysates of P7 GNPs from knockin Atoh1Flag mice were submitted to Flag immunoprecipitation and analyzed by immunoblotting directed against Flag, Atoh1
p-S328, and Atoh1 p-S339.
(G) Lysates from GNPs purified from the cerebella of P7 Atoh1Flag or wild-type mice were subjected to immunoprecipitation with anti-Flag antibody. The resulting
complexes were immunoblotted with antibodies against Flag and Huwe1.
(H) Lysates from GNPs purified from the cerebella of P7 wild-type GNPs infected with retroviruses encoding Atoh1-FH (WT) or Atoh1-2SA-FH (2SA) were
subjected to immunoprecipitation with anti-Flag, and the resulting complexes were immunoblotted with antibodies against Atoh1 and Huwe1.
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dent interaction, immunoprecipitated Atoh1-HA was left un-
treated or treated with Lambda protein phosphatase. Analysis
of complexes by immunoblotting showed that unphosphorylated
Atoh1-HA failed to coimmunoprecipitate HUWE1 (Figure 2D). To
further validate the role of S328 and S339 phosphorylation in the
Atoh1-HUWE1 interaction, we performed TAP using Atoh1
phosphodeficient mutants. Interestingly, a single point mutation
(S328A or S339A) did not abrogate the interaction, whereas
the double mutant (2SA) failed to precipitate HUWE1 (Figure 2E).
We next investigated the interaction in GNPs. First, we took
advantage of Atoh1Flag knockin mice (Flora et al., 2009) and
found that Atoh1 was phosphorylated at S328 and S339
in P7 GNPs (Figure 2F). Second, we immunoprecipitated
Atoh1-Flag from P7 GNPs and found that Atoh1-Flag
coimmunoprecipitated Huwe1, demonstrating an endogenous
interaction between Atoh1 and Huwe1 in GNPs (Figure 2G).
Next, we overexpressed Atoh1-FH andAtoh1-2SA-FH in purified
P7 GNPs and uncovered that the double mutant failed to immu-
noprecipitate Huwe1 in GNPs (Figure 2H). Taken together, these
findings suggest that the interaction between Atoh1 and Huwe1Develis mediated through Atoh1 phosphorylation at both serine 328
and serine 339 in primary GNPs.
Atoh1 Protein Stability Is Regulated by Huwe1
To investigate whether Huwe1 affected the steady-state levels of
Atoh1, we transduced NIH 3T3 cells with retroviruses encoding
Atoh1 together with a small hairpin RNA (shRNA) targeting
Huwe1 (sh-Huwe1) or a nontargeting shRNA as control (sh-Ctrl).
Efficient silencing of Huwe1 resulted in higher levels of Atoh1
protein compared to cells expressing sh-Ctrl (Figure 3A, lanes
1 and 2), comparable to that observed in cells after treatment
for 8 hr with MG132, a proteasome inhibitor (Figure 3A, lanes 2
and 3). Also, immunofluorescence experiments demonstrated
thatHuwe1-depleted NIH 3T3 cells had a stronger Atoh1 nuclear
signal than cells infectedwith sh-Ctrl retroviruses (Figure 3B).We
next investigated the impact of HUWE1 on Atoh1 levels. Overex-
pression of full-length HUWE1 induced remarkable reduction of
Atoh1 protein, whereas a HUWE1 catalytic deficient mutant
(HUWE1-CA) showed no effect on Atoh1 levels (Figure 3C). Strik-
ingly, Atoh1-2SA mutant was insensitive to HUWE1 wild-type
overexpression (Figure 3C).opmental Cell 29, 649–661, June 23, 2014 ª2014 Elsevier Inc. 651
Figure 3. Atoh1 Stability Is Regulated by the
E3 Ubiquitin Ligase Huwe1
(A) NIH 3T3 cells infected with retroviruses
encoding Atoh1 and sh-Ctrl (lane 1 and 3) or
sh-Huwe1 (lane 2) were treated with DMSO (lanes
1 and 2) or MG132 (lane 3). Protein lysates were
immunoblotted with antibodies against Atoh1,
Huwe1, and Actin.
(B) NIH 3T3 cells infected with retroviruses
expressing sh-Ctrl, untreated (a–c) or treated
with MG132 (g–i), or sh-Huwe1 (d–f) were dou-
ble-labeled for GFP (green, panels a, d, and g)
and Atoh1 (red, panels b, e, and h). Nuclei were
stained with DAPI (blue, panels c, f, and i). The
scale bar represents 60 mm. Relative Atoh1
signal intensity was quantified using ImageJ
software. Data are expressed as means ± SD
(n = 3).
(C) U2OS cells were transfected with indicated
plasmids. Atoh1 levels were determined by
immunoblotting using anti-HA. Actin was used
as loading control.
(D) NIH 3T3 cells infected with retroviruses
encoding Atoh1-HA (upper panel) or Atoh1-2SA-
HA (lower panel) and sh-Ctrl or sh-Huwe1 were
treated with 10 mM cycloheximide (Chx) and har-
vested at the indicated times. The levels of Huwe1
and Atoh1 in the lysates were investigated by
immunoblotting. Actinwas used as loading control.
(E) Quantification of Atoh1/Actin remaining pro-
tein from (D).
(F) U2OS cells transduced with Atoh1-HA,
His-ubiquitin (His-Ub), and HUWE1 full length
or HUWE1-CA were treated with MG132
for 8 hr. After lysis, ubiquitylated species
were recovered by Ni agarose pull-down (His
Pull-Down). Atoh1 ubiquitylation (upper panel)
and total Atoh1 levels (lower panel) were
determined by immunoblotting with an anti-HA
antibody.
(G) NIH 3T3 cells transduced with Atoh1-HA,
His-ubiquitin (His-Ub), and sh-Ctrl or sh-Huwe1
were treated with MG132 for 8 hr. After His pull-down, Atoh1 ubiquitylation (upper panel) and total Atoh1 levels (lower panel) were determined by
immunoblotting with an anti-HA antibody.
(H) NIH 3T3 cells transduced with Atoh1-HA (WT) or Atoh1-2SA-HA (2SA) and His-ubiquitin (His-Ub) were treated with MG132 for 8 hr. Atoh1
ubiquitylation (top) and total Atoh1 levels (bottom) were determined by immunoblotting with an anti-HA antibody.
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expressing sh-Ctrl or sh-Huwe1 together with Atoh1-HA wild-
type or Atoh1-2SA-HA mutant. Upon Huwe1 knockdown,
Atoh1 wild-type displayed enhanced protein stability, with its
half-life increasing from 30 min to 70 min (Figures 3D and 3E).
In contrast, the half-life of Atoh1-2SA-HAmutant was unaffected
by Huwe1 knockdown, suggesting that Atoh1 wild-type stability
was dependent on both its phosphorylation status and Huwe1
(Figures 3D and 3E).We next testedwhether HUWE1 could regu-
late Atoh1 protein levels via ubiquitylation and proteasomal
degradation. We treated cells expressing Atoh1-HA and His-
ubiquitin (His-Ub) in the presence or absence of HUWE1 for
8 hr upon MG132 treatment. Ectopic expression of HUWE1 led
to an increase in polyubiquitin chains on the Atoh1 protein,
whereas a catalytic deficient HUWE1-CA failed to polyubiquiti-
nate Atoh1 (Figure 3F). Conversely, when NIH 3T3 cells were
transduced with sh-Huwe1 compared to cells infected with sh-
Ctrl and treated withMG132, Atoh1 protein levels were stabilized652 Developmental Cell 29, 649–661, June 23, 2014 ª2014 Elsevier Iand Atoh1 polyubiquitylation was greatly reduced (Figure 3G).
Consistent with our previous results, the Atoh1-2SA-HA polyubi-
quitylation pattern strictly mirrored the absence of Huwe1 in cells
(compare Figures 3G and 3H). Collectively, these data demon-
strate that HUWE1 controls the degradation of the Atoh1
phosphorylated form at S328 and S339 in mammalian cells.
Huwe1 Controls Atoh1 Protein Levels and Function in
GNPs
To get insights into Atoh1 regulation in GNPs, we first inactivate
Huwe1 expression in GNPs. We purified P7 GNPs and infected
them with viruses encoding sh-Huwe1 or sh-Ctrl. As expected,
upon Huwe1 knockdown, endogenous Atoh1 levels were
increased after 48 hr in GNPs (Figure 4A). To study the regulation
of Atoh1 protein levels by Huwe1 in vivo, we conditionally
deleted Huwe1 in Atoh1-expressing cells using Huwe1-floxed
and Atoh1CreERT2 (Atoh1CreER) mouse strains. Because Huwe1
is an X-linked gene, we conducted the analysis on malenc.
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Huwe1F/Y;Atoh1CreER males were injected with tamoxifen at P1
and P2 (P1/P2), and proliferating GNPs were purified from the
cerebella of P9-treated pups. Immunoblotting analysis demon-
strated that Atoh1 protein levels were considerably increased
in GNPs from Huwe1F/Y;Atoh1CreER male pups (Figure 4B),
whereas levels of Atoh1 mRNA (Figure S3A) and Mycn protein,
a known target of Huwe1 in the cortex, were left unchanged (Fig-
ure S3B). To further validate our results, we assayed the
accumulation of Atoh1 upon Huwe1 silencing at the single-cell
level. Toward this aim, we took advantage of the Rosa-
lox-STOP-lox-EYFP (RosaYFP) mouse strain. Huwe1F/+ females
were crossed with Atoh1CreER;RosaYFP males, resulting
in Huwe1+/Y;Atoh1CreER;RosaYFP and Huwe1F/Y;Atoh1CreER;
RosaYFP animals. Male pups were treated with tamoxifen at
P1/P2. We first sorted yellow florescent protein (YFP)-positive
cells and confirmed that the cells were depleted for Huwe1 pro-
tein by immunoblotting (Figure S3C). We next examined Atoh1
protein levels by immunofluorescence in P9 purified GNPs
from Huwe1+/Y;Atoh1CreER;RosaYFP and Huwe1F/Y;Atoh1CreER;
RosaYFP tamoxifen treated animals at P1/P2. We observed a sig-
nificant increase in Atoh1 levels in Huwe1 null compared to
Huwe1-wild-type GNPs, demonstrating that loss of Huwe1
increased Atoh1 levels at the single-cell level (Figure 4C). We
next investigated Atoh1 expression in cerebellar tissue sections.
We crossed Atoh1GFP with Huwe1F/F;Atoh1CreER and injected
tamoxifen at P1/P2. GFP staining on tissue sections from P12
Huwe1F/Y;Atoh1CreER;Atoh1GFP revealed that Atoh1 levels were
greatly increased within the EGL in vivo, with a mosaic pattern
(Figure 4D). We next detected Atoh1 at the endogenous level
in tissue sections at P14 and found that Atoh1 accumulates in
the EGL upon Huwe1 deletion (Figure 4E). We analyzed P21
cerebella from Huwe1F/+;Atoh1CreER and Huwe1F/Y;Atoh1CreER
littermates injected with tamoxifen at P1/P2. Hematoxylin and
eosin as well as NeuN staining revealed the presence of
differentiated granule cell clusters at the surface of the
Huwe1F/Y;Atoh1CreER male mouse cerebellum, whereas
no clusters were found in control animals (Figure S3D). To deter-
mine whether Atoh1 accumulation affected Atoh1 function, we
measured the expression of Atoh1 target genes, including
Sema7a (Ayrault et al., 2010; Klisch et al., 2011) and Rab15
(Klisch et al., 2011; Lai et al., 2011). As shown in Figure S3E,
an increase in Sema7a and Rab15 mRNA levels was detected
in GNPs lacking Huwe1 when compared to control, whereas
Mycn targets were not increased under the same conditions
(Figure S3F).
We next interrogated proliferation and differentiation status in
Huwe1 null GNPs. In contrast to Mycn, Atoh1 does not increase
GNP proliferation in the absence or presence of SHH but rather
maintains GNPs in an undifferentiated state, which could be
further activated by SHH (Ayrault et al., 2010). In Huwe1 null
GNPs (YFP+), we found no significant increase of proliferation
after bromodeoxyuridine (BrdU) pulse (Figure S4A), and consis-
tent with Atoh1 function, we found that differentiation was in-
hibited as shown by the reduction of NeuN (differentiation
marker) and p27kip1 (postmitotic marker) in Huwe1 null GNPs
(Figure S4A). Thus, we interrogated the responsiveness of
Huwe1 null GNPs to SHH. Interestingly, Huwe1 null compared
to Huwe1-wild-type GNPs did not exhibit a proliferative advan-Develtage in the absence of SHH (Figure 4F). Furthermore, Huwe1
deletion enhanced the mitogenic response of cells after SHH
deprivation and subsequent SHH activation (Figure 4F). Hence,
these findings suggest that Huwe1 deletion in GNP mimics
Atoh1 overexpression phenotype by allowing the GNPs to
respond to SHH activation.
SHH Signaling Regulates Atoh1 Stability in GNPs
Signaling pathways including SHH and bone morphogenic pro-
teins (BMPs) control the balance between cell proliferation and
differentiation in the developing cerebellum. We first examined
Atoh1 protein levels in response to SHH or BMP signaling
upon Huwe1 deletion in GNPs. Immunoblotting showed a rapid
degradation of Atoh1 in the absence of SHH that was fully
rescued by Huwe1 deletion in GNPs (Figure 4G). As expected,
we observed a decrease in Atoh1 mRNA levels after 24 hr in
the absence of SHH; nonetheless, mRNA reduction was similar
in bothHuwe1 null andHuwe1-wild-type conditions (Figure S4B).
We next investigated whether SHH signaling could alter Huwe1
expression. We cultured P7 GNPs in the presence or absence
of SHH and observed that Huwe1 expression was not affected
(Figure S4C). Interestingly, BMP-2 treatment induced Atoh1
degradation independently of Huwe1 status (Figure 4G). We
next enforced Atoh1-HA and Atoh1-2SA-HA expression in
GNPs followed by BMP-2 treatment for 8 hr. Strikingly, in both
cases, BMP-2 induced Atoh1 degradation (Figure S4D). Our
data therefore suggest that BMP-2 induced Atoh1 degradation
and consequently neuronal differentiation through a Huwe1-
and Atoh1 phosphorylation (S338 and S339)-independent
mechanism. Since SHH was implicated in Huwe1-mediated
degradation of Atoh1, we assessed Atoh1’s half-life in response
to SHH signaling. In the presence of SHH, Atoh1 protein levels
were unchanged whether Huwe1 was deleted or not. However,
in the absence of SHH, Atoh1’s half-life was reduced, whereas
Huwe1 loss reversed this effect (Figures 4H and 4I). Importantly,
Atoh1 mRNA levels were unchanged in the absence of SHH
(Figure S4E). This strongly suggests that SHH signaling controls
Atoh1 stability via Huwe1 in primary GNPs. Altogether, our data
show that SHH andHuwe1 control Atoh1 protein levels and func-
tion in cerebellar granule neuron progenitors in vivo.
SHH Inhibits Atoh1 S328 and S339 Phosphorylation and
Protects Atoh1 from Huwe1-Mediated Degradation
Wenext investigate whether SHH could control Atoh1 phosphor-
ylation. We first used 2D gel electrophoresis to monitor total
Atoh1 phosphorylation in GNPs and observed that 8 hr of SHH
deprivation induced an increase of Atoh1 hyperphosphorylated
forms (Figure 5A). We also used a Smoothened inhibitor
(GDC-0449) (Robarge et al., 2009) to acutely inhibit SHH
signaling. Consistent with our previous results, addition of
GDC-0449 also induced hyperphosphorylation of Atoh1 (Fig-
ure 5A). We next investigated whether Atoh1’s phosphorylation
at S328 and S339 could be specifically regulated in response
to SHH signaling. We thus purified P7 GNPs from knockin
Atoh1Flag mice and treated the cells in culture with GDC-
0449 for 8 hr. We immunopurified Atoh1-Flag followed by
immunoblotting against Atoh1 phosphospecific antibodies.
As expected, upon SHH inhibition, Atoh1 levels were reduced
while Atoh1 phosphorylation at both S328 and S339 wasopmental Cell 29, 649–661, June 23, 2014 ª2014 Elsevier Inc. 653
Figure 4. The E3 Ubiquitin Ligase Huwe1 Controls Atoh1 Protein Levels and Function in Granule Neuron Progenitors
(A) Purified P7 GNPs from wild-typemice were infected with viruses encoding sh-Ctrl or sh-Huwe1 for 48 hr. Lysates were analyzed by immunoblotting with anti-
Atoh1 and anti-Huwe1 antibodies. Anti-Actin was used as loading control.
(B) GNPs purified from the cerebella of P9 Huwe1F/Y (#1 to #3) and P9 Huwe1F/Y;Atoh1CreER (#4 to #6) treated with tamoxifen at P1/P2 were analyzed by
immunoblotting with anti-Atoh1 and anti-Actin.
(C) GNPs purified from the cerebella of P9Huwe1+/Y;Atoh1CreER;RosaYFP andHuwe1F/Y;Atoh1CreER;RosaYFPmale mice and treated with tamoxifen at P1/P2 were
plated, maintained in culture for 24 hr, and stained with anti-Atoh1 (red, panels a and e), with anti-GFP to mark YFP+ GNPs (green, panels b and f), and with DAPI
counterstaining for the visualization of nuclei (blue, panels c and g). Three-color merging is presented in panels d and h. The scale bar represents 20 mm. Graph
representing Atoh1 relative signal intensity from (C) was quantified using ImageJ software. Data are expressed as means ± SD (n = 3).
(D) Expression of the Atoh1-GFP protein (GFP, green) in P12 cerebellar sections of Huwe1F/Y;Atoh1GFP and Huwe1F/Y;Atoh1CreER;Atoh1GFP mice treated with
tamoxifen at P1/P2. Nuclei were counterstained with DAPI (blue). Two-color merging is presented (Merge). White brackets indicate the EGL. The scale bar
represents 10 mm.
(E) Immunofluorescence of P14 cerebellum from Huwe1F/Y and Huwe1F/Y;Atoh1CreER mice treated with tamoxifen at P1/P2 with an anti-Atoh1 antibody (green).
Nuclei were counterstained with DAPI (blue). Two-color merging is presented (Merge). White brackets indicate the EGL. The scale bar represents 10 mm.
(F) GNPs were purified from P9 Huwe1+/Y;Atoh1CreER;RosaYFP (n = 3) and Huwe1F/Y;Atoh1CreER;RosaYFP (n = 3) pups treated with tamoxifen at P1/P2. GNPs were
culturedeither in the absenceof SHH for 48hr (black columns) or deprived of SHH for 24 hr and restimulatedwithSHH for 24hr (gray columns) and then labeledwith
BrdU for 2 hr. The percentage of YFP-positive cells (YFP+) that incorporated BrdU was determined by immunofluorescence. Data are presented as means ± SD.
(G)Huwe1F/Y andHuwe1F/Y;Atoh1CreERmales were treated with tamoxifen at P1/P2. Purified P9GNPswere cultured with or without SHH or with SHH and BMP-2
for 24 hr. Endogenous Atoh1 protein was detected by immunoblotting. Actin was used as loading control.
(legend continued on next page)
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Figure 5. SHHControls Atoh1 Phosphoryla-
tion and Protects Atoh1 from Huwe1-Medi-
ated Degradation
(A) Immunoblot analysis of Atoh1 after 2D gel
electrophoresis of lysates from purified P7 GNPs
cultured in the presence/absence of SHH for 8 hr
or in the presence of SHH and GDC-0449 for 8 hr.
Numbers represent, in percentage, the distribution
of Atoh1 protein.
(B) P7 GNPs from Atoh1Flag mice were cultured
with SHH in presence or in absence of GDC-
0449 for 8 hr. Flag immunoprecipitation was
conducted and Atoh1 was analyzed by immu-
noblotting with antibodies against Flag, Atoh1 p-
S328, and Atoh1 p-S339. Atoh1 phosphorylation
was significantly increased by 1.6-fold ± 0.25-
fold on S328 and 2.61-fold ± 0.92-fold on S339
(n = 4).
(C) Purified P7 wild-type GNPs were cultured in
the presence or absence of SHH for 24 hr.
Indicated PP2A regulatory subunits were
analyzed by quantitative RT-PCR. Data are ex-
pressed as means ± SD (n = 3).
(D) Purified P7 wild-type GNPs were cultured in
presence of okadaic acid (OA) or cantharidin for
5 hr and with OA or cantharidin and MG132 for
5 hr. Proteins in lysates were analyzed using
anti-Atoh1 and anti-Actin antibodies (n = 3).
(E) Purified P7 wild-type GNPs infected with retroviruses encoding GFP or SV40 small T (Small T) were maintained in culture for 48 hr. Lysates were analyzed
by immunoblotting with anti-Atoh1 and anti-Actin.
(F) Immunoblot of Atoh1 after 2D gel electrophoresis of lysates from purified P7 GNPs cultured in the presence of OA for 5 hr.
(G) P7 GNPs from Atoh1Flag mice were cultured in the presence of OA and MG132 for 3 hr. Flag immunoprecipitation was conducted and Atoh1 was
analyzed by immunoblotting with antibodies against Flag, Atoh1 p-S328, and Atoh1 p-S339. Atoh1 phosphorylation was significantly increased by 2.07-
fold ± 0.62-fold on S328 and 3.33-fold ± 1.02-fold on S339 (n = 4).
(H) OA treatment in GNPs previously infected with a retrovirus encoding either Atoh1-HA (WT) or Atoh1-2SA-HA (2SA). Protein lysates were analyzed using
anti-HA and anti-Actin antibodies (n = 3).
(I) OA treatment in GNPs purified from the cerebella of P9 Huwe1F/Y and Huwe1F/Y;Atoh1CreER males and treated with tamoxifen at P1/P2. Proteins from
lysates were analyzed using anti-Atoh1 and anti-Actin antibodies (n = 3).
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ure 5B). Altogether, our data demonstrate that SHH signaling
controls Atoh1 phosphorylation at S328 and S339 in neuronal
progenitors.
We next sought to explore the detailed mechanism controlling
Atoh1 phosphorylation via SHH. It was previously reported that
SHH activates the protein phosphatase PP2A family in GNPs
(Sjostrom et al., 2005). We confirmed that PP2A activity was in-
hibited in the absence of SHH or treated with GDC-0449 for 24 hr
(Figure S5) and that expression of several regulatory PP2A sub-
units were downregulated in the absence of SHH (Figure 5C). To
explore whether PP2A could control Atoh1 levels in GNPs, we
treated wild-type P7GNPs with okadaic acid (OA) or cantharidin,
both inhibitors of serine/threonine protein phosphatases with
greater activity toward the PP2A family. In both conditions, we
observed a rapid degradation of Atoh1 in a proteasome-depen-
dent manner (Figure 5D). We also overexpressed in GNPs SV40
small T antigen, a specific PP2A inhibitor (Chen et al., 2004; Sjos-
trom et al., 2005), and found that enforced expression of small T(H) GNP cells purified from the cerebella of P9 Huwe1F/Y (n = 3) and Huwe1F/Y;Ato
presence (upper panel) or the absence (lower panel) of the mitogen SHH. GNPs
times. Levels of Atoh1 in lysates were investigated by immunoblotting. Actin wa
(I) Quantification of Atoh1/Actin remaining protein from (H). Data are expressed a
Develreduced endogenous Atoh1 levels in primary GNPs (Figure 5E).
We next investigated whether the PP2A complex could modu-
late Atoh1 phosphorylation. Treatment of P7 GNPs with OA
induced Atoh1 hyperphosphorylation in GNPs assessed by 2D
electrophoresis (Figure 5F) as well as an increase in Atoh1 phos-
phorylation at both S328 and S339 by 2.07- and 3.33-fold,
respectively (Figure 5G). Furthermore, the Atoh1-2SA-HA
mutant was found insensitive to OA treatment (Figure 5H).
Finally, endogenous Atoh1 levels were significantly rescued in
Huwe1 null GNPs treated with OA (Figure 5I). Overall, our
findings demonstrate that SHH protects Atoh1 from degradation
mediated by the E3 ubiquitin ligase Huwe1 by regulating Atoh1
phosphorylation at both S328 and S339 through PP2A activity.
Atoh1 Degradation by Huwe1 Is Required for Proper
Neuronal Migration and Differentiation
To evaluate the relevance of Atoh1 as a target of Huwe1
in GNPs, we used cerebellar organotypic cultures. Cerebella
slices from P9 C57BL/6J mice were electroporated withh1CreER males (n = 3) and treated with tamoxifen at P1/P2 were cultured in the
were treated with 10 mM cycloheximide (Chx) and harvested at the indicated
s used as loading control.
s means ± SD (n = 3).
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SHH Regulates Atoh1 in Neural Precursorsnontargeting small interfering RNA (siRNA) (si-Ctrl), siRNA
against Huwe1 (si-Huwe1), or siRNA against Atoh1 (si-Atoh1)
together with pCAG-IRES-GFP (pCIG2-GFP) to mark electro-
porated cells. After 3 days in culture, we quantified the distance
of GFP-labeled cells from the surface of the EGL. Remarkably,
most of the GNPs expressing si-Huwe1 were confined to the
EGL (77.97% versus 38.85% observed in the control), whereas
GNPs expressing si-Ctrl had entered the molecular layer (ML)
and the IGL (Figures 6A and 6B). Enforced expression of
Atoh1-HA resulted in a strong accumulation of GNPs in the
EGL (77.88%), a fraction similar to that observed in GNPs
expressing si-Huwe1 (77.97%), demonstrating the requirement
of Atoh1 in preventing exit from the EGL (Figures 6A and 6B).
Because Atoh1 accumulated in Huwe1 null GNPs, we hypoth-
esized that the Huwe1 null phenotype could be attributed to
Atoh1 accumulation and subsequently to migration defects of
GNPs. We thus examined whether the migration defects,
induced by Huwe1 knockdown, could be rescued by silencing
Atoh1 expression. Strikingly, double silencing of Huwe1 and
Atoh1 rescued the migration defects observed in si-Huwe1-
treated GNPs (Figures 6A and 6B). This result indicates that
Atoh1 degradation by Huwe1 is required for migration of
GNPs during cerebellar development.
Migration defects detected upon Huwe1 deletion were
also associated with defects in neuronal differentiation. We
electroporated cerebellar organotypic cultures with pCIG2-GFP
together with si-Ctrl, si-Huwe1, or si-Huwe1 together with
si-Atoh1 and used p27Kip1 and NeuN as markers. Upon Huwe1
silencing, only 32.41% of GNPs expressed the postmitotic
marker p27Kip1 in the EGL, whereas 71.4%were p27Kip1 positive
after si-Ctrl expression (Figures 6C and 6D). Similar results were
obtained with the mature neuronal marker NeuN (Figures 6E and
6F). We next examined whether the deletion of Atoh1 could
rescue differentiation defects observed in Huwe1-null GNPs.
Remarkably, Atoh1 inactivation significantly rescued the differ-
entiation defects observed in si-Huwe1-treated GNPs, resulting
in 62.63% p27Kip1-positive cells in the EGL compared to
32.41% upon Huwe1 silencing (Figures 6C and 6D). Differentia-
tion rescued by Atoh1 silencing in Huwe1-null GNPs was
confirmed by immunostaining with NeuN (Figures 6E and 6F).
Altogether, Atoh1 is a functional target of the E3 ubiquitin ligase
Huwe1 in the developing cerebellum.
Low Expression of HUWE1 in Human SHH MB Is
Associated with a Poor Survival Outcome
Atoh1 is strongly expressed in mouse and human primary SHH
MB samples (Lee et al., 2003; Ayrault et al., 2009). We thereforeFigure 6. Atoh1 Downregulation by the E3 Ubiquitin Ligase Huwe1 Is R
Organotypic slices were prepared from the cerebella of P9 C57BL/6J mice electr
with si-Atoh1, or pCIG2-Atoh1-HA-GFP and cultured for 3 days.
(A) Slices were stained with GFP (green) and DAPI (blue). Representative confoc
layer), the IGL (internal granule layer), and the ML (molecular layer).
(B) Percent distribution of GFP-labeled cells according to the distance from the
distribution of control cells expressing si-Ctrl. The results shown are mean ± SD
(C) Organotypic slices double labeled with GFP (green) and p27Kip1 (red). White
(D) Results of quantitative analyses confirmed the rescue of the Huwe1 null diff
means ± SD (n = 3; 250 cells counted per experiment).
(E) Organotypic slices stained with GFP (green) and NeuN (red). White arrows in
(F) Quantification of GFP-positive and NeuN cells in the EGL. Data are expresse
Develhypothesized that the expression of Huwe1, negative regulator
of Atoh1, could be altered in mouse SHH MBs. We looked at
Huwe1 levels in spontaneous SHH MBs from tumor-prone
Ptch1+/ heterozygous mice (Goodrich et al., 1997) and found
Huwe1 protein levels lower if not absent as compared to P7
GNPs (Figure 7A). We further confirmed in tissue sections that
Huwe1 was either absent or present in very small amounts, con-
trasting with its expression in the adjacent cerebral cortex (Fig-
ures 7B, S6A, and S6B). Together, these findings indicate that
Huwe1 is downregulated in mouse SHH MBs. We next interro-
gated whether low HUWE1 levels were associated with a poor
outcome in human MB. We stratified MB patients for which
follow-up information and survival data were available into high
and low HUWE1 expression based on median cutoff selection
from patients within SHH, non-SHH (including WNT, group 3
and group 4 patients), group 3, and group 4 of MBs (Cho et al.,
2011). Strikingly, the Kaplan-Meier analysis showed that low
HUWE1 expression is associated with a poor prognosis only
within the SHH subgroup (Figure 7C). Ultimately, the association
of HUWE1 levels and survival specifically in SHH MB samples
highlights the relevance of the developmental machinery in
SHH MB tumorigenesis (Figure 7D).
DISCUSSION
Here, we identified a posttranslational mechanismwhereby SHH
signaling controls the level of Atoh1, a master regulator of cere-
bellar development. Hence, we show that Atoh1 is regulated by
SHH signaling, which prompts to a feedback loop between
Atoh1 and HUWE1 in order to control cerebellar development.
Our findings also show that Atoh1 accumulation in postnatal
GNPs impairs cerebellar development, which further illustrates
the functional significance of this mechanism.
In our study, we identified specific Atoh1 phosphorylation sites
using mass spectrometry. Twelve phosphorylation sites were
found clustered either in Atoh1’s N-terminal or C-terminal do-
mains, including seven proline-directed kinase motifs (S/T-P).
Among the 12 phosphorylation sites identified, only two sites
(S328 and S339) are responsible for both Atoh1 stability and its
interaction to Huwe1. However, we cannot rule out that the other
ten Atoh1 phosphorylation sites could also be implicated in
protein-protein interactions that would affect other functions of
Atoh1, as previously seen for other bHLH transcription factors.
For instance, Neurogenin 2 contains two phosphorylation sites
(S231 and S234), which are responsible for its interaction with
homeodomain transcription factors in order to specify motor
neuron identity (Ma et al., 2008).equired for Proper Cerebellar Development
oporated with pCIG2-GFP together with si-Ctrl, si-Huwe1, si-Atoh1, si-Huwe1
al images are shown. Dashed white lines delineate the EGL (external granule
surface of the EGL (n = 3; 600 cells per experiment). Red bars indicate the
(n = 3; 600 cells per experiment).
arrows indicate stained GNPs.
erentiation phenotype by Atoh1 silencing in the EGL. Data are expressed as
dicate stained GNPs.
d as means ± SD (n = 3; 250 cells counted per experiment).
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Figure 7. HUWE1 Expression Is Associated with a Poor Prognosis in Human SHH Medulloblastoma
(A) Levels of Huwe1 and Atoh1 proteins in GNPs purified from cerebella of P7 and MB tumor cells from mouse SHH MBs. Actin was used as a loading control.
Numbers indicate mouse identification numbers.
(B) Immunofluorescence staining of sagittal sections frommouse SHHMBs. Huwe1 staining (red) was carried out onMB tissues. Nuclei were counterstained with
DAPI (blue). Dashed white lines delineate MB (medulloblastoma), ML (molecular layer), and IGL (internal granule layer). P, Purkinje cells. Numbers indicate mouse
identification numbers. Magnification was 403.
(C) MB patients were stratified into high and low HUWE1mRNA expression based on median cutoff selection from patients within SHHMB, non-SHHMB (WNT,
groups 3 and 4), and groups 3 and 4 of MBs (Cho et al., 2011). Only MB patients for which follow-up information and survival data were available were included in
the Kaplan-Meier analysis.
(D) Schematic representation of the crosstalk between SHH signaling and Atoh1. Left: SHH prevents Huwe1-mediated degradation of Atoh1 by inducing PP2A
activity. Phosphorylated Atoh1 is polyubiquitylated by Huwe1 and subsequently degraded by the proteasome. Right: during postnatal cerebellar development,
Atoh1 is at the crosstalk betweenGNPs proliferation and neuronal differentiation. In SHHMB, disruption of this balance leads to activation of cell proliferation and
inhibition of cell differentiation.
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in inner ear hair cells (Bermingham et al., 1999), spinal cord inter-
neurons (Bermingham et al., 1999; Helms and Johnson, 1998),
Merkel cells in the skin (Ben-Arie et al., 2000), and secretory
goblet, Paneth, and enteroendocrine cells in the intestine
(Yang et al., 2001; Shroyer et al., 2007). Atoh1 has also paradox-
ically opposite effects in different tissues. During normal devel-658 Developmental Cell 29, 649–661, June 23, 2014 ª2014 Elsevier Iopment, Atoh1 expression is associated with the proliferation
of GNPs, which contrasts with the induction of differentiation in
sensory hair cells (Bermingham et al., 1999). In cancer, enforced
Atoh1 expression inPtch1+/GNPs leads toMB formation in vivo
(Ayrault et al., 2010), whereas Atoh1 loss is associated with colo-
rectal cancer and Merkel cell carcinoma (Bossuyt et al., 2009).
This dual role of Atoh1 may be due to distinct posttranslationalnc.
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SHH Regulates Atoh1 in Neural Precursorsmodifications that dictate Atoh1’s tissue-specific role. Hence,
determination of Atoh1 phosphorylation and tandem affinity
purification in a tissue-specificmannermay decipher tissue-spe-
cific paradoxical functions of Atoh1.
Atoh1 is central to the integration of several developmental
pathways such as SHH, BMP, and NOTCH signaling. SHH and
BMP signaling are known to establish the balance between pro-
liferation and differentiation in many systems. In postnatal GNPs,
BMP inhibits SHH-dependent proliferation via posttranslational
degradation of Atoh1 and induces neuronal terminal differentia-
tion (Zhao et al., 2008a). Our results demonstrate that both SHH
andBMP signaling regulate Atoh1 at the protein level, reinforcing
the importance of a tight regulation of Atoh1 for controlling the
switch between proliferation and differentiation. We also found
that BMP opposes SHH-dependent proliferation of GNPs by
inhibiting Atoh1 expression through an alternative molecular
mechanism, independent of Atoh1 phosphorylation and Atoh1’s
HUWE1-mediated degradation. This suggests that BMP may
use an as-yet-unidentified E3 ubiquitin ligase to downregulate
Atoh1 posttranslationally in GNPs (Zhao et al., 2008a). Although
the mitogen SHH is expressed throughout life after birth (Lewis
et al., 2004), BMP signaling may be used to protect against
persistent Atoh1 expression to guaranty terminal neuronal
differentiation.
Previous studies demonstrated that HUWE1 regulates the sta-
bility of important target proteins, including p53 (Chen et al.,
2005), Mcl1 (Zhong et al., 2005), Cdc6 (Hall et al., 2007), Mycn
(Zhao et al., 2008b), and MyoD1 (Noy et al., 2012). Deletion of
Huwe1 in Bergmann glial cells as well as in GNP cells using the
GFAPCre mouse line leads to the expansion of Mycn-positive
GNPs in the EGL during cerebellar development (D’Arca et al.,
2010). AsMycn is a direct target of SHH signaling and is required
for cerebellar development (Knoepfler et al., 2002), we therefore
investigated a potential role of Mycn in our model. Our data
demonstrate that Mycn protein levels as well as Mycn targets
Cdc25a, Ccnd1, Ccnd2, and Cdkn2c were not affected by dele-
tion of Huwe1 in GNPs using the Atoh1CreER mouse line. While
Atoh1 and Mycn have common functions in cerebellar develop-
ment, they also show separate and distinct functions in postnatal
cerebellar development. Unlike Atoh1, Mycn overexpression in
GNPs in vitro promotes cell-cycle progression in the absence
of SHH (Kenney et al., 2003; Oliver et al., 2003). Interestingly,
our data show that deletion of Huwe1 using Atoh1creER did not
enhance GNP proliferation in the absence of SHH. This is in
agreement with previous findings demonstrating that overex-
pression of Atoh1 cannot support GNP proliferation in the
absence of SHH but rather maintains GNPs in a SHH-responsive
state (Ayrault et al., 2010). Thus, deletion of Huwe1 in GNPs
mimics the effect of Atoh1 overexpression. There is a growing
consensus that the EGL is not composed of an homogeneous
population of committed Atoh1+ GNPs but includes cells of
multiple lineages, including GFAP+ precursors that migrate
through the ML and differentiate into postmitotic granule cells
in the IGL (Okano-Uchida et al., 2004; Machold and Fishell,
2005; Silbereis et al., 2010; Li et al., 2013). It has been proposed
that the cerebellar GFAP+ progenitors in the EGL are separate
from the Atoh1+ progenitors, and therefore the specific deletion
of Huwe1 in GFAP+ precursor cells using the GFAPCre deleter
strain may explain some of the differences observed using theDeveltwo experimental systems. Since Mycn is a functionally relevant
substrate of Huwe1 (Zhao et al., 2008b, 2009), we speculate
that coordination of the cell cycle and differentiation may
be executed through parallel pathways that are regulated by
Huwe1 in a cell-type- and time-dependent manner.
Atoh1 is overexpressed in mouse and human SHH MBs (Lee
et al., 2003; Ayrault et al., 2009), and the overproduction of
both Atoh1 and Gli1 guaranties SHH-subgroup MB formation
in an orthotopic transplantation model (Ayrault et al., 2010). In
this report, we described a molecular mechanism involving the
E3 Huwe1 that controls Atoh1 levels during cerebellar develop-
ment. In the cancer situation, we uncovered that Huwe1 is
strongly downregulated in murine SHH tumors. Interestingly, in
human SHH MB, the subgroup-specific prognostic impact of
HUWE1mRNA expression further underlines the role of this reg-
ulatory network in SHH MB biology. The proposed prognostic
role of HUWE1 warrants validation in prospective trials. How-
ever, these expression differences already suggest distinct bio-
logical subsets orchestrated by HUWE1 specifically within this
subgroup. In line with these findings, increasing data support
the notion that HUWE1 is a tumor suppressor. For instance, focal
hemizygous deletions of HUWE1 were found in glioblastoma
(Zhao et al., 2009). Intriguingly, a recent functional genomic
study using a sleeping beauty transposon system in SHH MB
in vivo revealed that insertions into theHuwe1 locus are enriched
in spine and brain metastases (Wu et al., 2012). Altogether,
disruptions of this developmental mechanism could explain the
addiction of MB cells for Atoh1 to ensure tumor propagation.
Therefore, as the use of small molecules inhibiting SHH activa-
tion are promising in the clinic but unfortunately associated
with drug resistance (Rudin et al., 2009; Yauch et al., 2009), we
could envision targeting SHHMB through a combination therapy
inhibiting both SHH signaling and Atoh1 through the Huwe1
pathway. We also found that inhibition of serine/threonine phos-
phatases induces rapid downregulation of Atoh1. Intriguingly,
the regulatory subunit PPP2R2B was found to be amplified in
SHH MBs (Northcott et al., 2012). Thus, inhibition of PP2A might
be of interest in therapeutic investigations of SHH MB.
In conclusion, we found a mechanism that regulates the
balance between proliferation and differentiation of neuronal
progenitors. Hence, a better understanding of deregulations of
this signaling pathway in SHH MBs should facilitate the identifi-
cation of potential targets for therapeutic interventions.EXPERIMENTAL PROCEDURES
Animal Husbandry
Pups at various postnatal ages were obtained from C57BL/6J mice. Sponta-
neous SHH MBs were obtained from Ptch1+/ mice (Jackson Laboratory,
003081) (Goodrich et al., 1997). Huwe1F/+ females (Zhao et al., 2009)
were crossed with Atoh1CreERT2 (Atoh1CreER) males (Jackson Laboratory,
007684) (Machold and Fishell, 2005) to generate Huwe1F/Y;Atoh1CreER males
and Huwe1F/+;Atoh1CreER females. For lineage tracing, we used the RosaYFP
reporter line (Jackson Laboratory, 006148). Atoh1Flag (referred to as
Atoh1tm6.1Hzo; Flora et al., 2009) and Atoh1GFP (referred to as Atoh1tm4.1Hzo;
Rose et al., 2009) knockin mice were obtained from Jackson Laboratory
(013595 and 013593, respectively). The care and use of animals strictly
followed European and national regulations in force for the protection of verte-
brate animals used for experimental and other scientific purposes (Directive
86/609). The protocol complies with internationally established 3R principles,
more precisely in accordance with United Kingdom Coordinating Committeeopmental Cell 29, 649–661, June 23, 2014 ª2014 Elsevier Inc. 659
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function during cerebellar normal development and medulloblastoma’’
got ethical approval (#2011-0012) from the reporting ethical committee IDF-
Paris-Comite´ 1.
Generation of Phosphospecific a-Atoh1 p-S328 and p-S339
Antibodies
Rabbit polyclonal antibodies were raised against two phosphopeptides
from mouse Atoh1: H2N-CEDNSKTS(PO3H2)PRSHR-CONH2 (p-S328) and
H2N-CRSDGEFS(PO3H2)PHSHY-CONH2 (p-S339); affinity purification was
performed by Eurogentec.
Phosphorylation and Mass Spectrometry Analysis
HEK293T cells overexpressing Atoh1 or Atoh1-F were lysed in 1% SDS radio-
immunoprecipitation assay buffer (25 mM Tris-HCl [pH 7.6], 150mMNaCl, 1%
NP-40, 1% sodium deoxycholate, and 1% SDS). Atoh1-F was purified using
anti-Flag M2 affinity gel (Sigma). Elutions were run on SDS-PAGE and, after
colloidal blue staining, the band corresponding to Atoh1 was submitted to
mass spectrometry analysis. For phosphopeptide analysis, probes were
directly loaded onto a LC-MS/MS.
Tandem Affinity Purification and Mass Spectrometry Analysis
HEK293T cells were transfected with pcDNA3-Atoh1 wild-type, pcDNA3-
Atoh1-FH, or pcDNA3-Atoh1-2SA-FH. After transfection, cells were har-
vested and lysed in TAP buffer (20 mM Tris-HCl [pH 8.0], 100 mM KCl,
5 mM MgCl2, 0.1% Tween 20, 0.1% NP40, and 10% glycerol and protease
inhibitors). A total of 10 mg of lysate was incubated for 4 hr at 4C with anti-
Flag M2 affinity gel (Sigma). The pulled-down proteins were eluted with
3xFlag peptide (Sigma). Eluates were incubated overnight with anti-HA
agarose beads (Sigma). Beads were washed with TAP buffer. After the last
wash, beads were split into two equal aliquots. One aliquot was subjected
to five elutions with 0.1 M glycine at pH 2.5. Eluates were neutralized with
1 M Tris-HCl (pH 8.0) and resolved by SDS-PAGE. The gel was then stained
with colloidal blue according to the manufacturer’s instructions (Fermentas).
The second aliquot was used for MudPIT analysis. The proteins on the beads
were digested overnight at 37C with sequencing-grade trypsin (Promega)
in 25 mM NH4HCO3. Digests were analyzed with an LTQ Velos Orbitrap
(Thermo Fisher Scientific) connected to an Easy Nano-LC Proxeon system
(Thermo Fisher Scientific).
Organotypic Slices
In vivo electroporation was performed on cerebella from P9 C57BL/6J mice.
Endotoxin-free pCIG2-GFP and pCIG2-Atoh1-HA-GFP plasmids, siRNA
(Atoh1, Huwe1, and Control Smart Pool; Dharmacon), and fast green (Sigma)
were injected between the pia membrane and the EGL. Cerebella were then
electroporated with platinum electrodes (Nepagene, CUY650P5) and a super
electroporator (Nepagene, NEPA21 type II). Electroporated cerebella were
sectioned sagittally into 300-mm-thick slices with a vibratome (VT1000S,
Leica). Slices were cultured for 3 days, fixed in 4% paraformaldehyde, and
immunostainedwithantibodies againstNeuN (Millipore), p27Kip1 (BDTransduc-
tion Laboratories), or GFP (Invitrogen). For each experiment, three slices from
three independent cerebella were analyzed by confocal microscopy (Leica,
SP5). For quantification of migrated GNPs, cerebellar boundaries were defined
using DAPI staining, which allows delineation of EGL, ML, and IGL. The migra-
tion distance was assessed using an ImageJ macro developed for measure-
ment of the shorter distance between GFP-positive cells and the cerebellar
pial surface. Images of GFP- or Cy3-positive cells were analyzed with ImageJ.
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